unknown node
unknown node
unknown node
unknown node
unknown node
unknown node
unknown node
unknown node
- unknown node
- unknown node
- unknown node
- unknown node
unknown node
Zoonotic & Outbreaks · Respiratory Infections · Regulatory & Compliance · Lab Operations
unknown node
unknown node
unknown node
unknown node
unknown node
Emergency readiness in diagnostics is pre-staged paperwork and platform flexibility: a living validation file per platform, mapped acceptance of EUL versus full prequalification per market, and instruments chosen to accept new assays without new capital orders.
Target audienceLab Director, Quality Manager, Program Lead
Compiled from public manufacturer materials and regulatory sources. Not independently verified and not reviewed by a named clinician.
2026-10-06
2026-10-06
professional use
FAQ
A time-limited WHO procedure that lists diagnostics for use in public-health emergencies when full prequalification is not yet available. Listing is condition-specific and does not automatically become permanent WHO prequalification.
No. National acceptance varies by jurisdiction. Mapping which pathway each regulator in your market accepts — full PQ, EUL, or stringent national approval — is readiness work worth doing in advance.
Verified specimen types, limit-of-detection evidence on your full extraction-amplification chain, interference and cross-reactivity notes, and the limitations quoted from the IFU — dated and versioned.
Emergency menus change faster than capital instruments. Open-validated platforms can adopt published emergency protocols without waiting for new hardware, which is usually the slowest line item to arrive.